NCT04948515

Gene Polymorphism of IL17 and IL 23

Association Between Gene Polymorphism of IL17 and IL 23 in Patients With COVID 19

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 120 (actual)
• Sponsor: Sohag University · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

rates are in such considerable amount among large population base. The pathogenesis of COVID-19 implicates a potent inflammatory response, involving a complex group of mediators including interleukins. These pleiotropic cytokines are secreted at the region of inflammation and released into the circulation by a variety of different cell types, including macrophages, lymphocytes, endothelial cells, epithelial cells during sepsis and acute organ injuries. There has recently found a number of studies reporting that the cytokine storms take part in the course of COVID-19

Detailed description

Aim Of The Study 1. To evaluate if there is an association between the IL-17, IL-23 gene polymorphism in Patients With COVID 19 by real-time PCR 2. To measure the serum level of IL17 by ELISA in COVID 19 patients by ELISA. 3. To detect if there is an association between gene polymorphism of IL17 and IL23 and severity of a condition in patients with COVID 19 Study design: a cross-sectional study. The blood samples will be collected from patient records in COVID19 isolation hospitals in sohag governorate and isolation department in sohag university hospitals.

Conditions

• COVID-19 Respiratory Infection

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	laboratory test	genotyping of IL 17 and IL23
DIAGNOSTIC_TEST	laboratory test	estimation of serum level of IL 17

Timeline

• Start date: 2021-06-03
• Primary completion: 2021-11-30
• Completion: 2021-12-03
• First posted: 2021-07-02
• Last updated: 2022-10-25

Locations

1 site across 1 country: Egypt